These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8279094)

  • 41. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleation and aggregation of calcium oxalate in whole urine; spectrophotometric sedimentation analysis: a new approach to study the aggregation of calcium oxalate dihydrate.
    Baumann JM; Affolter B; Caprez U; Lauper D; Maier F; Siegrist HP; Zysset T
    Urol Res; 2000 Jun; 28(3):147-54. PubMed ID: 10929422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.
    Sidhu H; Gupta R; Thind SK; Nath R
    Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effects of human urine on the adhesion of calcium oxalate crystal to renal tubular cells].
    Umehara M
    Nihon Hinyokika Gakkai Zasshi; 1998 Dec; 89(12):949-55. PubMed ID: 9990226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
    Khan SR
    Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis.
    Kok DJ; Papapoulos SE
    Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does urinary oxalate interfere with the inhibitory role of glycosaminoglycans and semisynthetic sulfated polysaccharides in calcium oxalate crystallization?
    Cao LC; Deng G; Boevé ER; Romijn JC; de Bruijn WC; Verkoelen CF; Schröder FH
    Eur Urol; 1997; 31(4):485-92. PubMed ID: 9187912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis.
    Levine BS; Rodman JS; Wienerman S; Bockman RS; Lane JM; Chapman DS
    Am J Clin Nutr; 1994 Oct; 60(4):592-6. PubMed ID: 8092096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors.
    Zerwekh JE; Hwang TI; Poindexter J; Hill K; Wendell G; Pak CY
    Kidney Int; 1988 May; 33(5):1005-8. PubMed ID: 3134570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium oxalate nephrolithiasis: an easy way to detect an imbalance between promoting and inhibiting factors.
    Baggio B; Gambaro G; Oliva O; Favaro S; Borsatti A
    Clin Chim Acta; 1982 Sep; 124(2):149-55. PubMed ID: 6216029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in-vivo effect of sodium-potassium citrate on the crystal growth rate of calcium oxalate and other parameters in human urine.
    Achilles W; Schulze D; Schalk C; Rodeck G
    Urol Res; 1990; 18(1):1-6. PubMed ID: 2316065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on crystalluria in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L
    Urol Res; 1984; 12(2):103-6. PubMed ID: 6539984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Calcium and citrate excretion by patients with calculi and healthy probands during induced acidosis].
    Bothor C; Berg W; Donner M; Pirlich W
    Urologe A; 1989 Mar; 28(2):112-5. PubMed ID: 2718293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.